CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 4 Open-market sale Director sold 8,028 shares at $33.91 ($272,225)
- 4 Open-market sale Director sold 116,554 shares at $34.24 ($3,990,378)
- 4 Open-market sale Chief Scientific Officer sold 14,166 shares at $34.83 ($493,413)
- 4 Open-market sale Director sold 340,000 shares at an average $33.84 ($11,504,564)
- 4 Open-market sale Director sold 250,000 shares at an average $26.68 ($6,670,678)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Other acquisition Director acquired 335,507 shares (other)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 18 of 20 · 399 filings